• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears IS2’s NuCammas

Article

Canadian gamma camera manufacturer IS2 Research reported this month that the Food and Drug Administration has cleared its two digital single-head gamma cameras for commercialization. The cameras, NuCamma C+ and NuCamma Rx, were designed by

Canadian gamma camera manufacturer IS2 Research reported this month that the Food and Drug Administration has cleared its two digital single-head gamma cameras for commercialization. The cameras, NuCamma C+ and NuCamma Rx, were designed by founder Iain Stark, formerly of Park Medical. They were introduced at this year’s Society of Nuclear Medicine meeting (SCAN 8/5/98).

NuCamma C+ has a circular field of view, while NuCamma Rx is a rectangular system. The electronics of both units are incorporated into their detectors, and the systems will carry list prices between $150,000 and $190,000. The Nepean, Ontario-based company has almost completed the manufacturing of its first batch of 10 cameras.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.